Togo

in page functions
[French]
Togo
Total population (2017) 7,691,914
Birth cohort (2017) 262,548
Surviving Infants (surviving to 1 year per year, 2017) 251,388
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 52/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 78/1000
World Bank Index, IDA (2015) 2.98
Gross Nation Income (per capita US$, 2015) 540
Co-financing group (2017) Initial self-financing
No. of districts/territories (2015) 40

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Togo

Type of support

Approvals

2001-2021 (US$)
(20 Dec 2016)

Commitments

2001-2021 (US$)
(20 Dec 2016)

Disbursements

2000-2016 (US$)
(20 Dec 2016)

% Disbursed

(20 Dec 2016)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $49,493,424 $68,177,924 $43,679,532
Cash Support (CASHSUPP) $188,000 $213,000 $188,000 100%
Civil Society Organisation support (CSO) $268,308 N/A
Health system strengthening (HSS 1) $3,643,081 $4,916,581 $3,643,081 100%
HPV Demo (NVS) $357,276 $357,276 $357,779 100%
Immunisation services support (ISS) $2,990,600 $2,990,600 $2,990,600 100%
Injection Safety Devices (NVS) $106,000 $444,000
Injection safety support (INS) $317,617 $317,617 $317,617 100%
IPV (NVS) $1,356,000 $1,356,000 $31,623 2%
Meningitis A - campaign (NVS) $2,063,527 $2,063,527 $2,063,614 100%
Meningitis A - operational costs (OPC) $1,744,601 $1,744,601 $1,744,601 100%
Penta (NVS) $15,417,413 $18,184,413 $15,044,340 98%
Pneumo (NVS) $13,120,581 $22,709,581 $10,232,913 78%
Rotavirus (NVS) $4,616,340 $8,362,340 $3,385,888 73%
Vaccine Introduction Grant (VIG) $853,500 $853,500 $845,066 99%
Yellow Fever (NVS) $2,718,888 $3,664,888 $2,566,102 94%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Togo DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 88%
M:F sex ratio at birth (2017) 1.02
Household survey: DTP3 coverage for male (2013) 84.20%
Household survey: DTP3 coverage for female (2013) 81.40%
Household survey: Last DTP3 survey (2013) 83%
% districts achieving > 80% DTP3 coverage (2015) 85%
% districts achieving < 50% DTP3 coverage (2015) 0%
MCV WHO/UNICEF estimates (2015) 85%

Breakdown of support

Non-vaccine support Vaccine support
23% 77%
$9,997,272 $33,682,255

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Togo

14 October 2016

Benin LOGIVAC

Africa takes second “step” toward strengthening supply chain management

New Strategic Training Executive Programme opens at Benin’s LOGIVAC+ Centre, 12 months after similar course offered in Rwanda

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

10 November 2015

Gavi item

Scientists mark 'stunning success' of vaccine in virtually ridding Africa of meningitis A

New research forecasts a resurgence of meningitis A epidemics in 15 years should immunization efforts stall.

close icon

modal window here